Cited by 180Dermatology and Skin DiseasesAdvancements in Transdermal Drug DeliverySkin and Cellular Biology Research

Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression

Open access
Grether-Beck, Susanne, Felsner, Ingo, Brenden, Heidi, Kohne, Zippora, Majora, Marc, Marini, Alessandra, Jaenicke, Thomas, Rodriguez-Martin, Marina +4 more·2012·Journal of Investigative Dermatology

Abstract

Urea is an endogenous metabolite, known to enhance stratum corneum hydration. Yet, topical urea anecdotally also improves permeability barrier function, and it appears to exhibit antimicrobial activity. Hence, we hypothesized that urea is not merely a passive metabolite, but a small-molecule regulator of epidermal structure and function. In 21 human volunteers, topical urea improved barrier function in parallel with enhanced antimicrobial peptide (AMP; LL-37 and β-defensin-2) expression. Urea stimulates the expression of, and is transported into, keratinocytes by two urea transporters (UTs), UT-A1 and UT-A2, and by aquaporins 3, 7, and 9. Inhibitors of these UTs block the downstream biological effects of urea, which include increased mRNA and protein levels of (i) transglutaminase-1, involucrin, loricrin, and filaggrin, (ii) epidermal lipid synthetic enzymes, and (iii) cathelicidin/LL-37 and β-defensin-2. Finally, we explored the potential clinical utility of urea, showing that topical urea applications normalized both barrier function and AMP expression in a murine model of atopic dermatitis. Together, these results show that urea is a small-molecule regulator of epidermal permeability barrier function and AMP expression after transporter uptake, followed by gene regulatory activity in normal epidermis, with potential therapeutic applications in diseased skin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/jid.2012.42

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Grether-Beck, S., Felsner, I., Brenden, H., Kohne, Z., Majora, M., Marini, A., Jaenicke, T., Rodriguez-Martin, M., Trullas, C., Hupe, M., Elias, P. M., & Krutmann, J.
Affiliations
  • Leibniz Institute of Environmental Medicine (DE)
  • San Francisco VA Medical Center (US)
Venue
Journal of Investigative Dermatology
Publisher
Elsevier BV
Published
2012-06
Volume
132
Issue
6
Pages
1561-1572
ISSN
0022-202X (ISSN-L)
OpenAlex
W2147701916
Cited by
180
References
67
Citations by year
2026: 9 · 2025: 6 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 13 · 2020: 13 · 2019: 8 · 2018: 13 · 2017: 9 · 2016: 16 · 2015: 19 · 2014: 25 · 2013: 11 · 2012: 6
FWCI
24.42
Type
journal article
Language
en
Open access
Locations
  • Journal of Investigative Dermatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Deutsche Forschungsgemeinschaft
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-19098, R01AR019098)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
Keywords
urea, skin permeability barrier, antimicrobial peptides, LL-37, human beta-defensin 2, cathelicidin, urea transporter, UT-A1, aquaporins, keratinocytes, epidermal gene expression, filaggrin, involucrin, loricrin, transglutaminase 1, epidermal lipids, atopic dermatitis, topical urea
MeSH terms
Epidermal Cells, Filaggrin Proteins, Urea Transporters, Adult, Animals, Cell Differentiation, Cell Membrane Permeability, Dermatitis, Atopic, Epidermis, Female, Gene Expression Regulation, Humans, Male, Mice, Hairless, Middle Aged, Urea, Water, Keratinocytes, Aquaporins, Antimicrobial Cationic Peptides, Membrane Transport Proteins, Mice, Aquaporin 3, Young Adult, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review